6 Multibagger Stocks That Surged After FIIs Corrected Their Mistake

While Foreign Institutional Investors (FIIs) have largely been viewed as bears on Dalal Street, a closer look at the data reveals a fascinating trend of selective re-entry. In several instances, FIIs significantly corrected their previous selling mistakes by accumulating specific stocks, leading to massive multibagger returns for early movers.

The Winners: Where FII Re-entry Fueled Massive Gains

According to data from ACE Equity, six specific stocks saw FIIs reverse their selling trends in the March quarter, following two consecutive quarters of outflows. This institutional "U-turn" acted as a powerful catalyst for price appreciation.

The most standout performer was Bajaj Consumer Care, which delivered an extraordinary one-year return of 265%. After systematically reducing their stake from 10.95% in June 2025 to 9.7% by December 2025, FIIs aggressively ramped up their holding to 16.59% in the March 2026 quarter. This move saw the stock price soar from ₹169.8 to ₹619.7.

Other notable multibaggers driven by this institutional shift include:

  • Acutaas Chemicals: FII holdings rose from 16.94% (June 2025) to 19.48% (March 2026), fueling a 187% price jump from ₹1,130.75 to ₹3,248.45.
  • SML Mahindra: Despite a massive initial sell-off where stakes dropped to just 0.61%, a pivot in the March 2026 quarter contributed to a 124.75% return.
  • Dee Development Engineers: A marginal directional shift in FII holding helped the stock rise 119% to reach ₹677.65.
  • United Foodbrands: Following a low point in September 2025, steady accumulation helped the stock climb 112% to ₹672.
  • RateGain Travel Technologies: FII ownership rebounded to 5.35% in March 2026, helping the stock double to ₹873.25.

Diverging Views: What the "Smart Money" Is Watching Now

As the market moves forward, major brokerage houses and fund managers are offering varying strategic outlooks based on shifting macro narratives.

Nuvama’s Strategy Team is eyeing demand-driven growth. They favor high dividend yield sectors and exporters, specifically overweighting consumer, cement, chemicals, IT, private banks, and pharma. Conversely, they remain underweight on industrials, metals, autos, and power.

JM Financial is taking a more defensive stance. Due to risks like high crude prices and rupee weakness, they have repositioned toward pharma, healthcare, oil and gas, and metals. They remain cautious on the banking and automobile sectors due to margin and earnings growth constraints.

Tata Mutual Fund is betting on large caps. They suggest that a potential US slowdown could boost emerging market flows, benefiting India. They believe large caps will outperform due to stable earnings and more attractive valuations compared to mid and small caps.

Long-term Outlook and Small-Cap Potential

Manish Gunwani, CIO for Equity at Bandhan AMC, projects long-term equity returns to stay 6% to 6.5% above inflation. While he sees fair valuations across the board, he finds the small-cap space most attractive for a three-to-five-year horizon. He specifically highlights manufacturing, global capex, defence, and energy security infrastructure as key growth areas driven by the global AI thematic and supply chain shifts.

Key Takeaways

  • FII Selective Accumulation: FIIs are not exiting the Indian market uniformly; they are making tactical "U-turns" in specific stocks, which has historically preceded multibagger returns.
  • Sector Divergence: Institutional views are split, with some favoring defensive plays like Pharma (JM Financial) and others favoring demand-led growth in Consumer and Chemicals (Nuvama).
  • Small-Cap Opportunity: Analysts see significant long-term value in small caps and manufacturing sectors, driven by structural changes in global supply chains and AI.